Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Repeatability of retinal thickness measurements between spectral-domain and time-domain optical coherence tomography images in macular disease.

Domalpally A, Gangaputra S, Peng Q, Danis RP.

Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec;41 Suppl:S34-41. doi: 10.3928/15428877-20100325-01. Epub 2010 Mar 30.

PMID:
20415296
2.

Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements.

Taban M, Sharma S, Williams DR, Waheed N, Kaiser PK.

Ophthalmology. 2009 May;116(5):964-70. doi: 10.1016/j.ophtha.2008.12.033.

PMID:
19410954
3.

Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema.

Diabetic Retinopathy Clinical Research Network Writing Committee, Bressler SB, Edwards AR, Chalam KV, Bressler NM, Glassman AR, Jaffe GJ, Melia M, Saggau DD, Plous OZ.

JAMA Ophthalmol. 2014 Sep;132(9):1113-22. doi: 10.1001/jamaophthalmol.2014.1698.

4.

Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices.

Ho J, Sull AC, Vuong LN, Chen Y, Liu J, Fujimoto JG, Schuman JS, Duker JS.

Ophthalmology. 2009 Oct;116(10):1960-70. doi: 10.1016/j.ophtha.2009.03.034. Epub 2009 Jul 9.

5.

Spectral domain optical coherence tomography in diabetic macular edema.

Pournaras JA, Erginay A, Lazrak Z, Gaudric A, Massin P.

Ophthalmic Surg Lasers Imaging. 2009 Nov-Dec;40(6):548-53. doi: 10.3928/15428877-20091030-03.

PMID:
19928719
6.

Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema.

Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT.

Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4290-6. doi: 10.1167/iovs.08-2113. Epub 2008 May 30.

7.

Comparison of optical coherence tomography models OCT1 and Stratus OCT for macular retinal thickness measurement.

Pierre-Kahn V, Tadayoni R, Haouchine B, Massin P, Gaudric A.

Br J Ophthalmol. 2005 Dec;89(12):1581-5.

8.

Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness.

Kiernan DF, Hariprasad SM, Chin EK, Kiernan CL, Rago J, Mieler WF.

Am J Ophthalmol. 2009 Feb;147(2):267-275.e2. doi: 10.1016/j.ajo.2008.08.018. Epub 2008 Oct 17.

PMID:
18929353
9.

Precision and reliability of retinal thickness measurements in foveal and extrafoveal areas of healthy and diabetic eyes.

Tangelder GJ, Van der Heijde RG, Polak BC, Ringens PJ.

Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2627-34. doi: 10.1167/iovs.07-0820.

PMID:
18515592
10.

Repeatability and reproducibility of retinal thickness measurements by optical coherence tomography in age-related macular degeneration.

Krebs I, Hagen S, Brannath W, Haas P, Womastek I, de Salvo G, Ansari-Shahrezaei S, Binder S.

Ophthalmology. 2010 Aug;117(8):1577-84. doi: 10.1016/j.ophtha.2010.04.032. Epub 2010 Jun 16.

PMID:
20557937
11.

Spectral-domain optical coherence tomography use in macular diseases: a review.

Wolf S, Wolf-Schnurrbusch U.

Ophthalmologica. 2010;224(6):333-40. doi: 10.1159/000313814. Epub 2010 May 4. Review.

PMID:
20453539
12.

Use of nonmydriatic spectral-domain optical coherence tomography for diagnosing diabetic macular edema.

Medina FJ, Callén CI, Rebolleda G, Muñoz-Negrete FJ, Callén MJ, del Valle FG.

Am J Ophthalmol. 2012 Mar;153(3):536-543.e1. doi: 10.1016/j.ajo.2011.08.008. Epub 2011 Oct 11.

PMID:
21996307
14.

Effect of macular edema on optical coherence tomography signal strength.

Hosseini H, Razeghinejad MR, Nowroozizadeh S, Jafari P, Ashraf H.

Retina. 2010 Jul-Aug;30(7):1084-9. doi: 10.1097/IAE.0b013e3181d8e7d1.

PMID:
20616685
15.

Increased-resolution OCT thickness mapping of the human macula: a statistically based registration.

Bernardes R, Santos T, Cunha-Vaz J.

Invest Ophthalmol Vis Sci. 2008 May;49(5):2046-52. doi: 10.1167/iovs.07-0467.

PMID:
18436839
16.

Comparison of three different optical coherence tomography models for total macular thickness measurements in healthy controls.

Menke MN, Dabov S, Sturm V.

Ophthalmologica. 2009;223(6):352-6. doi: 10.1159/000226600. Epub 2009 Jul 2.

17.

Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography.

Leung CK, Cheung CY, Weinreb RN, Lee G, Lin D, Pang CP, Lam DS.

Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4893-7. doi: 10.1167/iovs.07-1326. Epub 2008 Apr 30.

PMID:
18450592
18.

Influence of Retinal Pathology on the Reliability of Macular Thickness Measurement: A Comparison Between Optical Coherence Tomography Devices.

Bahrami B, Ewe SYP, Hong T, Zhu M, Ong G, Luo K, Chang A.

Ophthalmic Surg Lasers Imaging Retina. 2017 Apr 1;48(4):319-325. doi: 10.3928/23258160-20170329-06.

PMID:
28419397
19.

Quality issues in interpretation of optical coherence tomograms in macular diseases.

Domalpally A, Danis RP, Zhang B, Myers D, Kruse CN.

Retina. 2009 Jun;29(6):775-81. doi: 10.1097/IAE.0b013e3181a0848b.

PMID:
19373128
20.

Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.

Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M, Rothenbuehler SP, Enzmann V, Wolf S.

Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3432-7. doi: 10.1167/iovs.08-2970. Epub 2009 Feb 21.

PMID:
19234346

Supplemental Content

Support Center